Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01713634 · ClinicalTrials.gov registry record · NA

Dietary Intake Modifications to Protect Against Changes in Bone Metabolism

A NA study, sponsored by National Aeronautics and Space Administration (NASA).

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01713634 is a NA study that has completed, run by National Aeronautics and Space Administration (NASA). The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01713634, a NA study, has completed, sponsored by National Aeronautics and Space Administration (NASA).

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

Bone loss is not only a well-documented effect of spaceflight on astronauts, but also a condition that affects millions of men and women on Earth each year. Many countermeasures to bone loss have been proposed, and many have been evaluated to some degree. To date, those showing potential have focused on either exercise or pharmacological interventions, but none have targeted dietary intake alone as a factor to predict or minimize bone loss during spaceflight. The investigators proposed to document how the ratio of acid precursors to base precursors in the diet is related to directional changes in markers of bone resorption and formation during flight and recovery from flight. There is a high likelihood for success in predicting the extent of bone loss from dietary intake patterns of astronauts during spaceflight, given that this concept is strongly anchored in data obtained from ground-based experiments in our laboratory and others. The notion of manipulating diet to minimize bone loss could also have significant social and economic impacts for NASA and for the general public - especially given the increasing trends for diets that are high in animal protein and low in fruits and vegetables. The results of the proposed experiments will lead to development of a dietary countermeasure for bone loss consisting of a balanced diet with no associated risks for side effects that might be present with pharmaceuticals or supplements, no requirement for payload mass, and no additional crew time necessary during flight.

Interventions

  • OTHER Preflight
  • OTHER In-flight

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2009-01
Est. Completion 2015-11
Phase NA

What the Registry Record Tells You About NCT01713634

The ClinicalTrials.gov registry entry for NCT01713634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Aeronautics and Space Administration (NASA), which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Preflight is the first listed.

NCT01713634 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01713634 about?

NCT01713634 is a clinical study titled "Dietary Intake Modifications to Protect Against Changes in Bone Metabolism". Bone loss is not only a well-documented effect of spaceflight on astronauts, but also a condition that affects millions of men and women on Earth each year. Many countermeasures to bone loss have been proposed, and many have been evaluated to some degree. To date, those showing potential have focuse...

What is the current status of trial NCT01713634?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2009-01. Estimated completion is 2015-11.

What interventions are being tested in trial NCT01713634?

The interventions under investigation include: Preflight (OTHER), In-flight (OTHER).

Who is sponsoring clinical trial NCT01713634?

This trial is sponsored by National Aeronautics and Space Administration (NASA), which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.